Dr Ali Khalil, MBChB, PhD
Dr. Ali Khalil is a UK-licensed physician with over 20 years of medical experience spanning frontline clinical practice, academic research, and global clinical trials.
He trained and worked extensively in emergency medicine and acute care where he managed a wide spectrum of patients from everyday health concerns to life-threatening emergencies requiring rapid, critical decisions. His hands-on experience includes the care of oncology patients at their most vulnerable stages, supporting them through complex treatments and high-risk interventions.
Alongside his clinical practice, Dr. Khalil holds a PhD in Cardiovascular Medicine from the University of Leeds, UK, where he conducted advanced research and lectured in cardiovascular physiology. This strong academic foundation equips him with the ability to translate complex medical information into clear, evidence-based guidance for patients and families.
In clinical trials, Dr. Khalil has held senior roles designing and overseeing risk mitigation strategies, safety monitoring protocols, and management guidelines for experimental medicines in oncology and other specialties. He has been directly involved in patient monitoring ensuring that patient safety remains the highest priority.
Today, Dr. Khalil brings together his clinical expertise, academic knowledge, and international trial experience to help patients and families understand their medical conditions and test results, verify treatment plans against global standards and feel supported in making safe, informed health decisions with confidence
Dr Emma Harvey, MBBS, MRCGP, BSc
Dr. Emma Khalil is a UK-trained physician with over 10 years of clinical practice in the NHS and nearly a decade of leadership in the pharmaceutical industry.
She graduated in Medicine from St George’s Hospital Medical School, London, with a First-Class Honours BSc in Physiology and Medical Sciences. She went on to qualify as a Member of the Royal College of General Practitioners (MRCGP), alongside postgraduate diplomas from the Royal College of Obstetricians and Gynaecologists (DRCOG) and in Child Health (DCH).
Dr. Emma Khalil is registered with the UK General Medical Council (GMC, 4331603). Her career spans both frontline clinical medicine and senior global positions in oncology drug safety at a leading pharmaceutical company, where she has led safety strategy for breakthrough immuno-oncology medicines, overseen international clinical trials, and represented patient safety in major regulatory submissions and health authority reviews.
With this unique blend of hands-on patient care and global pharmaceutical expertise, Dr. Emma Khalil brings a wealth of knowledge to our service offering patients and families the reassurance of clear explanations, internationally benchmarked guidance, and a doctor’s perspective grounded in real clinical experience.